Skip to main content
. 2023 Apr 11;11(4):826. doi: 10.3390/vaccines11040826

Figure 2.

Figure 2

Distribution of studies selected for the efficacy of the Sinopharm, CoronaVac, and Covaxin vaccines for the prevention of COVID-19 [10,11,14,15,29,30,31,32,34,35,36,37,40,41,42,43,44,47,48,49].